0.00
100.00%
-0.455
Safeguard Scientifics, Inc. New stock is currently priced at $0.00, with a 24-hour trading volume of 0.
It has seen a -100.00% decreased in the last 24 hours and a -100.00% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.5135 pivot point. If it approaches the $0.0573 support level, significant changes may occur.
Previous Close:
$0.455
Open:
$0
24h Volume:
0
Market Cap:
$7.54M
Revenue:
-
Net Income/Loss:
$-10.29M
P/E Ratio:
0.00
EPS:
-0.89
Net Cash Flow:
$-3.09M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
Safeguard Scientifics, Inc. New Stock (SFE) Company Profile
Name
Safeguard Scientifics, Inc. New
Sector
Industry
Phone
610-293-0600
Address
170 North Radnor-Chester Road, Suite 200, Radnor, PA
Safeguard Scientifics, Inc. New Stock (SFE) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-27-18 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
Dec-07-17 | Resumed | Keefe Bruyette | Mkt Perform |
Jul-21-15 | Initiated | Barrington Research | Outperform |
Sep-27-12 | Initiated | Ascendiant Capital Markets | Buy |
Oct-12-11 | Reiterated | Stifel Nicolaus | Buy |
May-18-11 | Reiterated | Stifel Nicolaus | Buy |
Feb-14-11 | Reiterated | Stifel Nicolaus | Buy |
Oct-07-10 | Reiterated | Stifel Nicolaus | Buy |
Feb-22-10 | Initiated | Stifel Nicolaus | Buy |
May-02-08 | Reiterated | Boenning & Scattergood | Market Outperform |
Apr-02-08 | Reiterated | Boenning & Scattergood | Market Outperform |
Jun-13-07 | Initiated | Henley & Company | Buy |
View All
Safeguard Scientifics, Inc. New Stock (SFE) Latest News
Safeguard Scientifics Filed Form 25 to Voluntarily Delist its Common Stock from The Nasdaq Stock Market LLC
GlobeNewswire Inc.
Safeguard Scientifics Intends to File Form 25 to Voluntarily Delist its Common Stock from The Nasdaq Stock Market LLC
GlobeNewswire Inc.
Safeguard Scientifics Announces Effective Date of Stock Splits to Effectuate the Going Dark Transaction and New Chief Executive Officer and Chief Financial Officer
GlobeNewswire Inc.
Safeguard Scientifics Announces Stock Split Ratios to Effectuate the Going Dark Transaction
GlobeNewswire Inc.
Safeguard Scientifics’ Board of Directors Declares Contingent Cash Dividend of $0.35 Per Share
GlobeNewswire Inc.
Safeguard Scientifics Announces Third Quarter 2023 Financial Results
GlobeNewswire Inc.
Safeguard Scientifics, Inc. New Stock (SFE) Financials Data
Safeguard Scientifics, Inc. New (SFE) Net Income 2024
SFE net income (TTM) was -$10.29 million for the quarter ending September 30, 2023, a +42.93% increase year-over-year.
Safeguard Scientifics, Inc. New (SFE) Cash Flow 2024
SFE recorded a free cash flow (TTM) of -$3.09 million for the quarter ending September 30, 2023, a +42.47% increase year-over-year.
Safeguard Scientifics, Inc. New (SFE) Earnings per Share 2024
SFE earnings per share (TTM) was -$0.64 for the quarter ending September 30, 2023, a +40.19% growth year-over-year.
About Safeguard Scientifics, Inc. New
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and 0 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with an additional office in Weston, Massachusetts.
Cap:
|
Volume (24h):